II 
(Non-legislative acts) 
REGUL ATIONS 
COMMI SSION REGUL ATION (EU) 2020/171 
of 6 Febr uary 2020 
amending Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the 
Council concer ning the Regis tration, Evaluation, Author isation and Rest riction of Chemicals 
(REA CH) 
(Text with EEA relevance) 
THE EUR OPEAN COMMISSION, 
Havi ng regar d to the Treaty on the Functioning of the European Union, 
Havi ng regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 
concer ning the Registration, Evaluation, Author isation and Restr iction of Chemicals (REA CH), establishing a European 
Chemicals Agen cy, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission 
Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 
93/67/EEC, 93/105/EC and 2000/21/EC (1), and in particular Articles 58 and 131 thereof, 
Whereas: 
(1) The substances 1,2-benzenedicarbo xylic acid, dihexyl ester, branche d and linear , and dihexyl phthalat e and the 
substance group 1,2-benzenedicarbo xylic acid, di-C6-10-alkyl esters; 1,2-benzenedicarbo xylic acid, mixed decyl and 
hexyl and octyl dieste rs with ≥ 0,3 % of dihexyl phthalat e meet the criteria for classification as toxic for reproduction 
(categor y 1B) in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council (2) 
and theref ore meet the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) 
of that Regulation. 
(2) The substance trixylyl phosphat e meets the criteria for classification as toxic for reproduction (categor y 1B) in 
accordance with Regulation (EC) No 1272/2008 and theref ore meets the criteria for inclusion in Annex XIV to 
Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation. 
(3) The substances sodium perborate ; perbor ic acid, sodium salt and sodium pero xometaborate meet the criteria for 
classificat ion as toxic for reproduction (categor y 1B) in accordance with Regulation (EC) No 1272/2008 and 
theref ore meet the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of 
that Regulation. 
(4) The substances 5-sec-butyl-2-(2,4-dimethy lcyclohex-3-en-1-yl)-5-methyl-1,3-dio xane [1], 5-sec-butyl-2-(4,6- 
dimethylcy clohex-3-en-1-yl)-5-methy l-1,3-dio xane [2] (covering any of the individual stereoisomers of [1] and [2] 
or any combination thereof) are very persiste nt and very bioaccumulative in accordance with the criteria set out in 
Annex XIII to Regulation (EC) No 1907/2006 and theref ore meet the criteria for inclusion in Annex XIV to that 
Regulation set out in Article 57(e) of that Regulation. 
(5) The substances 2-(2H-benzotr iazol-2-yl)-4,6-dit ertpentylphenol (UV-328); 2,4-di-t ert-butyl-6-(5-ch loroben­
zotr iazol-2-yl)phenol (UV-327); 2-(2H-benzotr iazol-2-yl)-4-(ter t-butyl)-6-(sec-butyl)phenol (UV-350) and 2- 
benzotr iazol-2-yl-4,6-di-t ert-butylphenol (UV-320) are persiste nt, bioaccumulative and toxic and/or very persist ent 
and very bioaccumulative in accordance with the criteria set out in Annex XIII to Regulation (EC) No 1907/2006 
and theref ore meet the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(d) and/or (e) of 
that Regulation. 
(6) All the abov e-mentioned substances have been identif ied and included in the candidate list in accordance with 
Article 59 of Regulation (EC) No 1907/2006. They have further more been prioritised for inclusion in Annex XIV to 
Regulation (EC) No 1907/2006 by the European Chemicals Agen cy (‘the Agency’) in its recommendations of 
10 November 2016 (3) and 5 Febr uary 2018 (4), in accordance with Article 58(3) and (4) of that Regulation. In 
addition, the Commission has received submissions from interest ed parties to calls for information on the possible 
economic, social, health and environmental impacts (costs and benefits) of the inclusion in Annex XIV to 
Regulation (EC) No 1907/2006 of the substances proposed by the Agency in its draf t recommendations. 
(1)OJ L 396, 30.12.2006, p. 1. 
(2)Regulation (EC) No 1272/2008 of the European Parliament and the Council of 16 December 2008 on classific ation, labelling and 
packaging of substances and mixtures (OJ L 353, 31.12.2008, p. 1). 
(3)https://ec ha.europa.eu/documents/10162/13640/7th_axiv_recommendation_november2016_en.pdf 
(4)https://ec ha.europa.eu/documents/10162/13640/8th_axiv_recommendation_febr uary2018_en.pdf EN Offi cial Jour nal of the European Union 7.2.2020                                                                                                                                             L 35/1   (7) For each of the substances included in Annex XIV to Regulation (EC) No 1907/2006 by this Regulation a date from 
which the placing on the market and the use of the substance shall be prohibited unless an author isation is grant ed 
should be set as required by Article 58(1)(c)(i) of Regulation (EC) No 1907/2006, taking into account the Agency’s 
capacity to handle applications for author isation. For each of those substances there are no reasons why the date 
refer red to in Article 58(1)(c)(ii) of Regulation (EC) No 1907/2006 should be set earlier than 18 months before the 
date refer red to in Article 58(1)(c)(i) of that Regulation. 
(8) Article 58(1)(e) in conjunction with Article 58(2) of Regulation (EC) No 1907/2006 provid es for the possibility of 
exem ptions of uses or catego ries of uses in cases where specifi c Union legislation imposes minimum requirements 
relating to the prote ction of human health or the environment ensur ing proper control of the risks. In accordance 
with the information currently available it is not appropr iate to set exem ptions based on those provisions. 
(9) As there is no information justifying the need for an exem ption for product and process orientated research and 
development, it is not appropr iate to consider any such exem ption. 
(10) As the available information on the uses of the proposed substances is limite d, it is not appropr iate to set review 
periods at this stage, pursuant to Article 58(1)(d) of Regulation (EC) No 1907/2006. 
(11) The substances tetralead trioxide sulphate ; pentalead tetrao xide sulphate; orange lead (lead tetroxide) and lead 
mono xide (lead oxide) meet the criteria for classif ication as toxic for reproduction (categor y 1A) in accordance with 
Regulation (EC) No 1272/2008 and theref ore meet the criteria for inclusion in Annex XIV to Regulation (EC) 
No 1907/2006 set out in Article 57(c) of that Regulation. They have also been identified and included in the 
candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006 and prioritised for inclusion in 
Annex XIV to that Regulation by the Agen cy’s recommendation of 10 November 2016 in accordance with Article 
58(3) and (4) of that Regulation. The use of lead and its compo unds is covered by Council Directive 98/24/EC (5) 
and to some extent by Directive 2010/75/EU of the European Parliament and of the Council (6) and its 
imp lementing measures establishing Best Available Techniques (BAT) conclusions. Further more the current Union 
binding occupational limit value and binding biological limit value for lead compo unds under Directive 98/24/EC 
will be reviewed. Theref ore, and in view of possible adopt ion of more stringent measures at the workplace, it is 
appropr iate to postpone a decision on the inclusion of those substances in Annex XIV to Regulation (EC) No 
1907/2006. In addition, through implementation of Directive 2010/75/EU and its predecessors, emissions of lead 
and its compo unds to the environment have decreased and continue to decrease as shown by the European 
Pollutant Release and Transf er Regist er (E-PR TR) repor ting and further reductions are expected as new BAT 
conclusions are adopt ed and as permits are update d to reflect them. 
(12) All uses of 1-meth yl-2-p yrrolidone (NMP) are restr icted in accordance with Annex XVII to Regulation (EC) 
No 1907/2006. NMP has similar intrinsic proper ties to those of N,N-dimeth ylacetamide (DMA C) and N,N- 
Dimeth ylformamide (DMF), and the three substances have similar industr ial uses and may be considered as 
inter chang eable, at least for some uses, even if in general they cannot be considered ‘drop-in’ altern atives. In view of 
the similar ities of the three substances in order to ensure a consist ent regulatory approach (7), the decision on the 
inclusion of NMP in Annex XIV to Regulation (EC) No 1907/2006 should be postponed, as has been done for 
DMA C and DMF when the Commission considered the Agency’s recommendations of 17 Januar y 2013 (8) and of 6 
Febr uary 2014 (9), respectively . 
(13) In order to avoid the premature obsolescence of articles or complex products that are no longer produced after the 
sunset date s referred to in Annex XIV to Regulation (EC) No 1907/2006, some substances (by themselves or in 
mixtures) included in that Annex need to be available for the production of spare parts as articles or as compl ex 
products for the repair of those articles or complex products, where those articles or compl ex products cannot 
function as intended without those spare parts, as well as where some Annex XIV substances (by themselves or in 
mixtures) are necessar y for the repair of such articles or complex products. In order to facilitat e application for 
author isation for those uses, the existing transitional arrange ments should be extended, allowing the adopt ion of 
imp lementing measures for simplified application for author isations in such cases. In addition, the wording of the 
(5)Council Directive 98/24/EC of 7 Apr il 1998 on the prot ection of the health and safety of work ers from the risks relate d to chemical 
agen ts at work (fourteenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC) (OJ L 131, 5.5.1998, 
p. 11). 
(6)Directive 2010/75/EU of the European Parliament and of the Council of 24 November 2010 on industr ial emissions (integrat ed 
pollution prevention and control) (OJ L 334, 17.12.2010, p. 17). 
(7)https://ec ha.europa.eu/r moa/-/dislist/details/0b0236e181ffe81a 
(8)https://ec ha.europa.eu/documents/10162/13640/4th_a_xiv_recommendation_17jan2013_en.pdf 
(9)https://ec ha.europa.eu/documents/10162/13640/5th_a_xiv_recommendation_06feb2014_en.pdf EN Offi cial Jour nal of the European Union L 35/2                                                                                                                                              7.2.2020   note s to the table of Annex XIV to Regulation (EC) No 1907/2006 should be revised in order to ensure consist ency 
of the term inology as regards articles and compl ex products in the light of the judgement of the Cour t of Justice in 
Case C-106/14 (10). 
(14) Regulation (EC) No 1907/2006 should theref ore be amended according ly. 
(15) The measures provid ed for in this Regulation are in accordance with the opinion of the Committee established under 
Article 133 of Regulation (EC) No 1907/2006, 
HAS ADOPTED THIS REGUL ATION: 
Article 1 
Annex XIV to Regulation (EC) No 1907/2006 is amended in accordance with the Annex to this Regulation. 
Article 2 
This Regulation shall enter into force on the twentieth day followi ng that of its publication in the Official Journal of the 
European Union. 
This Regulation shall be binding in its entirety and directly applicable in all Member States. 
Done at Brussels, 6 Febr uary 2020.  
For the Commission 
The President 
Ursula VON DER LEYEN     
(10)Judgment of the Cour t of Justice of 10 Sept ember 2015, Fédération des entrepr ises du commerce et de la distr ibution (FCD) and 
Fédération des magasins de bricolage et de l’aménagement de la maison (FMB), C-106/14, ECLI:EU:C:2015:576. EN Offi cial Jour nal of the European Union 7.2.2020                                                                                                                                             L 35/3   ANNEX 
The table in Annex XIV to Regulation (EC) No 1907/2006 is amended as follows : 
(1) The followi ng entr ies are added:    
Transitional arrangements   
Entr y 
No Substance Intrinsic proper ty(ies) 
referred to in Article 57 Latest application date (1) Sunset date (2) Exemp ted (categories of) uses Review periods 
‘44. 1,2-Benzenedicarbo xylic acid, dihexyl ester, 
branche d and linear 
EC No: 271-093-5 
CAS No: 68515-50-4 Toxic for reproduction 
(categor y 1B) 27 August 2021 (*) 27 Febr uary 2023 (**) - - 
45. Dihexyl phthalate 
EC No: 201-559-5 
CAS No: 84-75-3 Toxic for reproduction 
(categor y 1B) 27 August 2021 (*) 27 Febr uary 2023 (**) - - 
46. 1,2-benzenedicarbo xylic acid, di-C6-10-alkyl 
esters; 1,2-benzenedicarbo xylic acid, mixed 
decyl and hexyl and octyl diesters with 
≥ 0,3 % of dihexyl phthalat e (EC No 
201-559-5) 
EC No: 271-094-0; 272-013-1 
CAS No: 68515-51-5; 68648-93-1 Toxic for reproduction 
(categor y 1B) 27 August 2021 (*) 27 Febr uary 2023 (**) - - 
47. Trixylyl phosphate 
EC No: 246-677-8 
CAS No: 25155-23-1 Toxic for reproduction 
(categor y 1B) 27 November 2021 (*) 27 May 2023 (**) - - 
48. Sodium perborate; perbor ic acid, sodium salt 
EC No: 239-172-9; 234-390-0 
CAS No: - Toxic for reproduction 
(categor y 1B) 27 November 2021 (*) 27 May 2023 (**) - - 
49. Sodium pero xometaborate 
EC No: 231-556-4 
CAS No: 7632-04-4 Toxic for reproduction 
(categor y 1B) 27 November 2021 (*) 27 May 2023 (**) - - 
50. 5-sec-butyl-2-(2,4-dimethy lcyclohex-3-en-1- 
yl)-5-meth yl-1,3-dio xane [1], 5-sec-butyl-2- 
(4,6-dimethy lcyclohex-3-en-1-yl)-5-methy l- 
1,3-dio xane [2] [covering any of the indivi­
dual stereoisomers of [1] and [2] or any com­
bination thereof] 
EC No: - 
CAS No: - vPvB 27 Febr uary 2022 (*) 27 August 2023 (**) - - EN Offi cial Jour nal of the European Union L 35/4                                                                                                                                              7.2.2020   Transitional arrangements   
Entr y 
No Substance Intrinsic proper ty(ies) 
referred to in Article 57 Latest application date (1) Sunset date (2) Exemp ted (categories of) uses Review periods 
51. 2-(2H-benzotr iazol-2-yl)-4,6-dite rtpentyl­
phenol (UV-328) 
EC No: 247-384-8 
CAS No: 25973-55-1 PBT, vPvB 27 May 2022 27 November 2023 - - 
52. 2,4-di-t ert-butyl-6-(5-chlor obenzotr iazol-2- 
yl)phenol (UV-327) 
EC No: 223-383-8 
CAS No: 3864-99-1 vPvB 27 May 2022 27 November 2023 - - 
53. 2-(2H-benzotr iazol-2-yl)-4-(ter t-butyl)-6- 
(sec-butyl)phenol (UV-350) 
EC No: 253-037-1 
CAS No: 36437-37-3 vPvB 27 May 2022 27 November 2023 - - 
54. 2-benzotr iazol-2-yl-4,6-di-t ert-butylphenol 
(UV-320) 
EC No: 223-346-6 
CAS No: 3846-71-7 PBT, vPvB 27 May 2022 27 November 2023 - -’ 
(1) Date referred to in Article 58(1)(c)(ii). 
(2) Date referred to in Article 58(1)(c)(i).   
(2) The sign ‘(*)’ is inser ted next to the date indicated in the ‘Latest application date’ column for the follo wing substance entr ies: 32-43. 
(3) The sign ‘(**)’ is inser ted next to the date indicated in the ‘Sunset date’ column for the follo wing substance entr ies: 32-43. 
(4) The note s after the table are replaced by the followi ng: 
‘(*) 1 Sept ember 2021 for the use of the substance in the production of spare parts as articles or as compl ex products for the repair of articles or compl ex products, the production of 
which ceased or will have ceased before the sunset date indicated in the entr y for that substance, where that substance was used in the production of those articles or compl ex 
products and these cannot function as intended without that spare part and the spare part cannot be produced without that substance, and for the use of the substance (on its 
own or in a mixture) for the repair of such articles or complex products where that substance on its own or in a mixture was used in the production of those articles or complex 
products and they cannot be repaired other wise than by using that substance. 
(**) 1 Marc h 2023 for the use of the substance in the production of spare parts as articles or as compl ex products for the repair of articles or complex products the production of 
which ceased or will have ceased before the sunset date indicated in the entr y for that substance, where that substance was used in the production of those articles or compl ex 
products and these cannot function as intende d without those spare parts and the spare part cannot be produced without that substance, and for the use of the substance (on its 
own or in a mixture) for the repair of such articles or complex products, where that substance on its own or in a mixture was used in the production of those articles or compl ex 
products and they cannot be repaired other wise than by using that substance. 
(***) Does not meet the criteria for identif ication as a carcinog en if it contains < 0,005 % (w/w) benzo[a]p yrene (Einecs No 200-028-5).’   EN Offi cial Jour nal of the European Union 7.2.2020                                                                                                                                             L 35/5